GeneCraft Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC (NCT06934590) | GeneCraft Inc. | 2025-05-01 |
Track GeneCraft Inc. automatically
Every clearance here is in the API, with alerts when new ones post.